Newsfeeds - Spark Newswire

4 minute read

Kezar Life Sciences Presents Complete Results From The MISSION Phase 2 Trial Evaluating Zetomipzomib In Lupus Nephritis At ASN’s Kidney Week 2022 Annual Meeting

Today, 4:08 AM

Zetomipzomib added to stable background therapy reduced proteinuria by 50% or greater (ORR) in 11 of 17 patients (64.7%) reaching end of treatment at Week 25. This benefit occurred with a 53% mean

KZR

4 minute read

InflaRx Climbs More Than 40%, Here’s 58 Biggest Movers From Yesterday

By Lisa Levin

Today, 4:08 AM

Gainers Agile Therapeutics, Inc. (NASDAQ: AGRX) shares climbed 89.8% to close at $2.41 on Tuesday. Agile Therapeutics shares climbed over 10% on Monday amid the Supreme Court overturning Roe V Wade.

ACIU

3 minute read

Dow Dips Over 400 Points; Crude Oil Rises 2%

By Lisa Levin

Today, 4:08 AM

U.S. stocks turned sharply lower toward the end of trading, with the Dow Jones dropping more than 400 points on Tuesday.

BPT

2 minute read

Movers

12 Health Care Stocks Moving In Tuesday’s Intraday Session

By Benzinga Insights

Today, 4:08 AM

Gainers

AGRX

3 minute read

Why Is Ceragon Networks Surging By 19%? 41 Stocks Moving In Tuesday’s Mid-Day Session

By Lisa Levin

Today, 4:08 AM

Gainers Agile Therapeutics, Inc. (NASDAQ: AGRX) jumped 88.9% to $2.3986. Agile Therapeutics shares climbed over 10% on Monday amid the Supreme Court overturning Roe V Wade.

AGRX

1 minute read

Why Kezar Life Sciences Stock Is Soaring Today

By Adam Eckert

Today, 4:08 AM

Kezar Life Sciences Inc (NASDAQ: KZR) shares are surging Tuesday after the company announced topline results from the MISSION Phase 2 clinical trial evaluating zetomipzomib.

KZR